26
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: not found

      Severe Sepsis and Septic Shock Associated with Chikungunya Virus Infection, Guadeloupe, 2014

      brief-report

      Read this article at

      ScienceOpenPublisherPMC
      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          During a 2014 outbreak, 450 patients with confirmed chikungunya virus infection were admitted to the University Hospital of Pointe-à-Pitre, Guadeloupe. Of these, 110 were nonpregnant adults; 42 had severe disease, and of those, 25 had severe sepsis or septic shock and 12 died. Severe sepsis may be a rare complication of chikungunya virus infection.

          Related collections

          Most cited references11

          • Record: found
          • Abstract: not found
          • Article: not found

          Gram-Negative Bacteremia

            Bookmark
            • Record: found
            • Abstract: found
            • Article: found
            Is Open Access

            EPIDEMIOLOGY, CLINICAL MANIFESTATIONS, AND DIAGNOSIS OF CHIKUNGUNYA FEVER: LESSONS LEARNED FROM THE RE-EMERGING EPIDEMIC

            Chikungunya fever, caused by “Chikungunya virus,” is an arbovirus disease transmitted by the bite of infected mosquitoes belonging to the genus Aedes. Chikungunya fever epidemics have been reported from several countries around the world. The disease that was silent for nearly 32 years re-emerged in the October 2005 outbreak in India that is still ongoing. The incubation period ranges from 3 to 12 days. The onset is usually abrupt and the acute stage is characterized by sudden onset with high-grade fever, severe arthralgias, myalgias, and skin rash. Swollen tender joints and crippling arthritis are usually evident. In the chronic stage, relapses that include sensation of fever, asthenia, exacerbation of arthralgias, inflammatory polyarthritis, and stiffness may be evident. Neurological, ocular, and mucocutaneous manifestations have also been described. Chronic arthritis may develop in about 15% of the patients. Viral culture is the gold standard for the diagnosis of Chikungunya fever. Reverse transcription polymerase chain reaction and real-time loop-mediated isothermal amplification have also been found to be useful. Serodiagnostic methods for the detection of immunoglobulin M and immunoglobulin G antibodies against Chikungunya virus are more frequently used. Chikungunya is a self-limiting disease; however, severe manifestations such as meningoencephalitis, fulminant hepatitis, and bleeding manifestations may sometimes be life-threatening. Treatment is symptomatic and supportive. Prevention by educating the community and public health officials, vector control measures appear to be the best approach at controlling Chikungunya fever as no commercially available vaccine is available for public use in India for this condition presently.
              Bookmark
              • Record: found
              • Abstract: not found
              • Article: not found

              Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013.

                Bookmark

                Author and article information

                Journal
                Emerg Infect Dis
                Emerging Infect. Dis
                EID
                Emerging Infectious Diseases
                Centers for Disease Control and Prevention
                1080-6040
                1080-6059
                May 2016
                : 22
                : 5
                : 891-894
                Affiliations
                [1]Centre Hospitalier Universitaire, Pointe-à-Pitre, France (A. Rollé, K. Schepers, E. Curlier, B. Madeux, C. Hermann-Storck, I. Fabre, I. Lamaury, G. Thiery, B. Hoen);
                [2]Cellule Interrégionale d’Epidémiologie Antilles-Guyane, Institut de Veille Sanitaire, Gourbeyre, France (S. Cassadou);
                [3]Centre d’Investigation Clinique 1424, Institut National de la Santé et de la Recherche Médicale, Pointe-à-Pitre (B. Tressières, B. Hoen);
                [4]Université des Antilles, Faculté de Médecine Hyacinthe Bastaraud, Pointe-à-Pitre (G. Thiery, B. Hoen)
                Author notes
                Address for correspondence: Bruno Hoen, Department of Infectious Diseases, Dermatology, and Internal Medicine, University Medical Center of Guadeloupe, BP 465, 97159 Pointe-à-Pitre CEDEX, Guadeloupe; email: bruno.hoen@ 123456chu-guadeloupe.fr
                Article
                15-1449
                10.3201/eid2205.151449
                4861514
                27088710
                c54afc2c-568a-4c8b-a419-e28ee645beef
                History
                Categories
                Dispatch
                Dispatch
                Severe Sepsis and Septic Shock Associated with Chikungunya Virus Infection, Guadeloupe, 2014

                Infectious disease & Microbiology
                chikungunya,chikv,severe sepsis,septic shock,vector-borne infections,viruses,guadeloupe,french west indies

                Comments

                Comment on this article